DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nitroimidazole
Nitroimidazole
National Antibiotic Consumption for Human Use in Sierra Leone (2017–2019): a Cross-Sectional Study
Identification of Leishmania Donovani Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
The Nitroimidazole Family of Drugs
The Organic Chemistry of Drug Synthesis
Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
Evidence of Pyrimethamine and Cycloguanil Analogues As Dual Inhibitors of Trypanosoma Brucei Pteridine Reductase and Dihydrofolate Reductase
The Organic Chemistry of Drug Synthesis
Stability Indicating HPLC Method for Simultaneous Estimation of Rifaximin and Metronidazole Hydrochloride Tablet Dosage Form Panchal Hemanshi*1, Thakkar Divya2 1
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Drug Resistance in the Sexually Transmitted Protozoan Trichomonas Vaginalis
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
(12) United States Patent (10) Patent No.: US 9,072,728 B2 Rufo Et Al
2-Amino-1,3,4-Thiadiazoles As Prospective Agents in Trypanosomiasis and Other Parasitoses
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Annual Report of Antibiotic and Antimycotic Consumption 2019
NDA Approval Letter
FLAGYL (Metronidazole) Is Contraindicated in Patients with a Prior History of Hypersensitivity to Metronidazole Or Other Nitroimidazole Derivatives
WARNING Metronidazole Has Been Shown to Be Carcinogenic in Mice and Rats
Top View
Efficacy of Levofloxacin and Rifaximin Based Quadruple Therapy in Helicobacter Pylori Associated Gastroduodenal Disease: a Double-Blind, Randomized Controlled Trial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Bacterial Challenges and Evolving Antibacterial Drug Strategy B
Rp-Hplc Method Development and Validation for Simultaneous Quantitative Estimation of Metronidazole and Nalidixic Acid in Tablets
European Patent Office of Opposition to That Patent, in Accordance with the Implementing Regulations
Carbadox and Metronidazole Induce VSH-1 and Facilitate Gene Transfer Among Brachyspira Hyodysenteriae Strainsᰔ Thaddeus B
2019 Antibacterial Agents in Clinical Development
Antibiotic Resistance Genes in the Actinobacteria Phylum
Chemotherapy
Antibiotics in the Clinical Pipeline in 2011
Addition of Rifaximin and N-Acetyl Cysteineto The
Tarif Intégré Des Communautés Européennes (TARIC)
Tindamax® (Tinidazole) Tablets for Oral Use • Seizures and Neuropathy Have Been Reported
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter Pylori: a Literature Review
WHO Methodology for a Global Programme on Surveillance of Antimicrobial Consumption
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Methods for Treating Bacterial Infection
Guidelines for ATC Classification and DDD Assignment 2011
The Effect of the Nitroimidazole Drug Dimetridazole on Microaerophilic Campylobacters D. S. Fernie, D. A. Ware* and R. W. A
Potency Boost of a Mycobacterium Tuberculosis Dihydrofolate Reductase Inhibitor by Multienzyme F420H2-Dependent Reduction
Pharmacological Issues with Bacterial Overgrowth: Causes and Treatment Strategies
Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
Antibiotics, Gastrointestinal Therapeutic Class Review (TCR)
METRONIDAZOLE Injection, USP 500 Mg (5 Mg/Ml) Single Dose Container Flexible Container for Intravenous Infusion Only
COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
Harmonized Tariff Schedule of the United States (2006) (Rev
Ornidazole: a New Antiprotozoal Compound for Treatment of Trichomonas Vaginalis Infection
Why Not Revisiting Tinidazole As Potential Treatment of Odontogenic Infections?
Designing New 5-Nitroimidazoles: Towards Safer Anti-Infectious Agents Maxime Crozet, Thierry Terme, Patrice Vanelle
Antibiotic Residue in the Aquatic Environment: Status in Africa 891 From, for Example, Landfill Sites [17]
Mechanisms of Selective Toxicity of Metronidazole and Other Nitroimidazole Drugs
Group Presentations
2018 Update of Antibacterial Agents in Clinical Development Is Based on the Outcome of the Second Advisory Group Meeting That Was Held on 12 July 2018
Medicinal Significance of Nitroimidazoles - Some Recent Advances
May Thesis (8.742Mb)
Schedule Clxxiii - European Union
Prohibited Drugs
Consumer Medicine Information for Ornidazole